Generic Name and Formulations:
Prazosin HCl 1mg, 2mg, 5mg; caps.
Indications for MINIPRESS:
Give 1st dose at bedtime. 1mg 2–3 times daily. Increase dose slowly. Usual dose: 6–15mg/day in divided doses; max 20–40mg/day. When adding another antihypertensive, reduce dose to 1–2mg 3 times daily and retitrate.
Syncope. Pregnancy (Cat.C). Nursing mothers.
Limit alcohol intake. Hypotension with propranolol, diuretics, other antihypertensives. False (+) pheochromocytoma test.
Syncope (esp. 1st dose), dizziness, headache, drowsiness, weakness, palpitations, GI upset, edema, orthostatic hypotension, dyspnea, vertigo, depression, nervousness, rash, urinary frequency, blurred vision, reddened sclera, epistaxis, dry mouth, nasal congestion; priapism (rare).
Caps 1mg, 2mg—250, 1000
Caps 5mg—250, 500
Neurology Advisor Articles
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- Loss of Function Variants in LRRK1 and LRRK2 Not Linked to Parkinson Disease
- Smoking Promotes Disease Progression in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- ZTlido Patch for Post-Shingles Pain Launching Soon
- Managing Complications of Intrathecal Baclofen Therapy
- Deep Brain Stimulation Reduces Tremor Symptoms in Parkinson Disease
- FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid
- Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored